TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
REPL

Replimune Group Inc

Healthcare · Biotechnology

13.10$ +1.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow REPL
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
-10.7% +35.8% +260.1% +221.0% +25.5% +14.0% +8.5% +31.9% +17.2%
+290.4% +236.2% +183.6% +52.3% +105.7% +16.0% +21.3% +2.7% -7.9%
+371.2% +390.5% -4.6% +63.2% +105.5%
+1,187.1% -166.2% +106.1% +109.0% -63.7% +339.2% -116.0%
-42.9% +1,811.8% +151.5% -63.4% -2.3% -2.8% +149.4% +18.1% -36.8%
+18,406.7% +49.7% -92.1% +3,507.4% -99.0% +7,790.5% -124.5%
+225.6%
+265.0% +85.2% -72.2% +225.6%
+0.0% +0.0% +0.6% -208.0% -97.6% -47.7% -104.1%
+265.0% +85.2% -1.2% +271.8% -98.2% +4,618.1% -94.8% +1,450.1% -73.7%
-148.1% +271.1% +259.2% -162.2% -277.3% +167.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?